Published in J Urol on August 01, 2001
A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens. Can Urol Assoc J (2012) 1.03
Response to targeted therapy in urachal adenocarcinoma. Rare Tumors (2014) 0.79
Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene (2007) 2.28
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia. Ann Intern Med (2000) 1.64
Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model. Jpn J Cancer Res (1997) 1.52
Value of the routine use of the cerebral dynamic radioisotope study. Radiology (1973) 1.44
Immunohistochemical analysis of nm23 protein in transitional cell carcinoma of the bladder. Br J Urol (1995) 1.40
Intravesical instillation of epirubicin: effect on tumour recurrence in patients with dysplastic epithelium after transurethral resection of superficial bladder tumour. Br J Urol (1996) 1.39
The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia (1998) 1.35
Electrocardiographic characteristics of left ventricular outflow tract tachycardia. Pacing Clin Electrophysiol (2000) 1.24
Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol (2008) 1.17
Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia (2003) 1.15
Congenital collateral urethral duplication in the frontal plane. J Urol (1999) 1.14
Inflammatory pseudotumor of the bladder: MR findings. J Comput Assist Tomogr (1999) 1.05
Interferon-induced sudden hearing loss. Audiology (1996) 1.04
Neoadjuvant chemotherapy for locally advanced urothelial cancer of the upper urinary tract. Urol Int (1995) 1.02
Structural studies on the chondroitinase ABC-resistant sulfated tetrasaccharides isolated from various chondroitin sulfate isomers. Carbohydr Res (1994) 0.97
Sudden hearing loss associated with interferon. Lancet (1994) 0.95
Urethral caruncle with coexistence of intestinal heterotopia. A case report. Int Urol Nephrol (1997) 0.94
Cluster outbreak of Pneumocystis pneumonia among kidney transplant patients within a single center. Transplant Proc (2009) 0.93
Efficacy of gemtuzumab ozogamicin on ATRA- and arsenic-resistant acute promyelocytic leukemia (APL) cells. Leukemia (2005) 0.92
[A reversible posterior leukoencephalopathy syndrome in a patient with classical polyarteritis nodosa]. Rinsho Shinkeigaku (1997) 0.89
Sucrase-isomaltase and hexose transporter gene expressions are coordinately enhanced by dietary fructose in rat jejunum. J Nutr (1999) 0.86
Reduced effect of gemtuzumab ozogamicin (CMA-676) on P-glycoprotein and/or CD34-positive leukemia cells and its restoration by multidrug resistance modifiers. Leukemia (2002) 0.86
ABO (H) blood group antigens and carcinoembryonic antigens as indicators of malignant potential in patients with transitional cell carcinoma of the bladder. J Urol (1984) 0.84
Activation of the visual cortex imaged by 24-channel near-infrared spectroscopy. J Biomed Opt (2000) 0.84
Proarrhythmic effects of fluoroquinolone antibacterial agents: in vivo effects as physiologic substrate for torsades. Toxicol Appl Pharmacol (2000) 0.83
Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring. Leukemia (2002) 0.83
Modulation of heat-induced cell death in PC-3 prostate cancer cells by the antioxidant inhibitor diethyldithiocarbamate. BJU Int (2002) 0.82
Bacillus Calmette-Guérin perfusion therapy for carcinoma in situ of the upper urinary tract. Br J Urol (1996) 0.82
Genomic heterogeneity in bladder cancer as detected by fluorescence in situ hybridization. Br J Urol (1996) 0.82
Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer. Cancer Res (2001) 0.81
Superoxide dismutase analog (Tempol: 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine 1-oxyl) treatment restores erectile function in diabetes-induced impotence. Int J Impot Res (2009) 0.81
Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. J Urol (1997) 0.81
Clinical significance of immunohistochemically detectable p53 protein in renal cell carcinoma. Eur Urol (1997) 0.81
Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog. Mamm Genome (1997) 0.81
Three-dimensional structure in language tests of aphasia. Folia Phoniatr (Basel) (1985) 0.80
Cardiac electrophysiologic and hemodynamic effects of sildenafil, a PDE5 inhibitor, in anesthetized dogs. J Cardiovasc Pharmacol (2001) 0.80
Downregulation of androgen, estrogen and progesterone receptor genes and protein is involved in aging-related erectile dysfunction. Int J Impot Res (2003) 0.80
A study of right unilateral spatial neglect in left hemispheric lesions: the difference between right-handed and non-right-handed post-stroke patients. Acta Neurol Scand (1992) 0.80
Cerebral blood volume in the sleep measured by near-infrared spectroscopy. Psychiatry Clin Neurosci (1998) 0.80
T antigen expression in benign hyperplasia and adenocarcinoma of the prostate. Urol Int (1987) 0.80
Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder. Eur Urol (1996) 0.80
Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder. J Clin Pathol (1996) 0.80
Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder. Cancer (1996) 0.80
Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis. Oncology (1999) 0.79
Bilateral upper ureteric disruptions caused by a traffic accident. Injury (1999) 0.79
Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer. Eur Urol (1996) 0.78
Efficacy of carboplatin-taxane combinations in the management of castration-resistant prostate cancer: a pooled analysis of seven prospective clinical trials. Ann Oncol (2009) 0.78
Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model. Biochem Biophys Res Commun (1997) 0.78
CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells. Leukemia (2009) 0.78
Heat-induced membrane damage combined with adriamycin on prostate carcinoma PC-3 cells: correlation of cytotoxicity, permeability and P-glycoprotein or metallothionein expression. Br J Urol (1998) 0.78
New ultrasonographic criterion for the prenatal diagnosis of cloacal exstrophy: elephant trunk-like image. J Urol (1999) 0.78
A clinical study of upper urinary tract calculi treated with extracorporeal shock wave lithotripsy: association with bacteriuria before treatment. Urol Int (1995) 0.78
Pulmonary nodules in patients with a history of radical nephrectomy for renal cell carcinoma. Int J Urol (1995) 0.78
Catheter ablation of ventricular tachycardia in patients with right ventricular dysplasia: Identification of target sites by entrainment mapping techniques. Pacing Clin Electrophysiol (1998) 0.78
Association of nm23 protein levels in human prostates with proliferating cell nuclear antigen expression at autopsy. Eur Urol (1996) 0.77
Isolated spinal neurosarcoidosis: an autopsy case. Spinal Cord (2010) 0.77
Comparison of chromosomal aberrations detected by fluorescence in situ hybridization with clinical parameters, DNA ploidy and Ki 67 expression in renal cell carcinoma. Br J Cancer (1998) 0.77
Biallelic mutations of the Tsc2 gene in chemically induced rat renal cell carcinoma. Int J Cancer (1998) 0.77
Superficial siderosis of the central nervous system. A case report on examination by ECoG and DPOAE. ORL J Otorhinolaryngol Relat Spec (2000) 0.77
Free groin flap for reconstruction of the tongue and oral floor. J Reconstr Microsurg (1998) 0.77
Inverted papilloma of the urinary bladder: a case evaluated for malignant potential. Int Urol Nephrol (1997) 0.76
Biological characteristics of inverted papilloma of the urinary bladder. Br J Urol (1996) 0.76
Effect of increasing dietary energy on hepatic lipogenesis in growing chicks. II. Increasing energy by fat or protein supplementation. Poult Sci (1983) 0.76
Quantitative analysis of NM23 protein immunoreactivity in renal cell carcinoma using an image analyzer. J Urol (1997) 0.76
Secondary plasmacytoma of the testis: report of a case. Int Urol Nephrol (1996) 0.76